Clinical Trials in Pittsburgh

Showing 10541-10560 of 16,007 trials

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

NCT01233375

The purpose of this study is to determine whether CO-1.01 is safe and effective for treating metastatic pancreatic cancer that did not respond to gemcitabine.

Metastatic Pancreatic Adenocarcinoma

Clovis Oncology, Inc.19 participantsStarted Apr 2011

Tucson, Arizona, United States • Denver, Colorado, United States • Boynton Beach, Florida, United States +10 more locations

COMPLETED< 1 mile

Lung Tissue Research Consortium

NCT02988388

The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate to the particular disease. The primary goal of the LTRC is to identify participants with suspected lung cancer or metastatic disease who are willing to provide informed consent for research use of their specimens and data. Secondarily, the LTRC investigators intend to collect clinical data, limited exposure data, physiologic studies, and radiographic studies from these participants.

Chronic Obstructive Pulmonary DiseaseInterstitial Lung Disease

National Heart, Lung, and Blood Institute (NHLBI)247 participantsStarted Feb 2017

Ann Arbor, Michigan, United States • Rochester, Minnesota, United States • Philadelphia, Pennsylvania, United States +1 more locations

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Lung Tissue Research Consortium

Find Trials by Condition in Pittsburgh

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Inflammation and the Host Response to Injury (Trauma)

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Driveline Silicone Skin Interface Registry

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Fresolimumab and Radiotherapy in Metastatic Breast Cancer